Human challenge studies, which involves the isolation of a volunteer, their deliberate exposure to an infectious agent and the continuous monitoring of their health via clinical assessments, biological sampling and other forms of data collection.
HVIVO has pioneered human challenge studies for 20 years and has built up a data and biobank from fully-consented volunteers that participated in internal hVIVO studies or the placebo arm of select trials which is now available for immediate analysis. hVIVO is now seeking a commercial partner to unlock potential insights associated with its world-leading work on infectious diseases.
Multiple viral challenges models
Our biobank includes multiple viral challenge models including Flu, HRV and RSV with SARS-COV-2 (COVID-19) soon to be included. Other models in development include Asthma exacerbation, COPD and Malaria.
Over 700 fully-consented patients
Fully-consented, specifically remunerated.
250,000 individual patient samples
Across a range of sample types (blood, serum, nasal) and for the full duration of the diseases’ progression.
Our Bio & Databank
For each patient, multiple samples types at various points before, during and after viral challenge and resolution are retained including Plasma, Serum, NPS, Nasal Wash, PAXgene RNA/DNA, Urine and others.
A range of measurements including immunological and virological information have already been conducted and are available, with the stored samples available for further characterisation upon request.
All datasets are accompanied by clinical notes associated with a patient’s individual state of health at any stage during the study including symptoms, symptom diary cards and patient vital signs.